Face It aims to offer services that are both evidence-based and complementary to clinical practices. To accomplish this, we rely on the guidance of our medical and scientific advisory board.

The advisory board is comprised of six internationally recognized experts in the treatment of depression and anxiety. These professionals help us ensure that our support offerings align with the latest research and clinical evidence about depression.

JOHN R. ADLER, MD

Dr. John Adler is a neurosurgeon, the Dorothy and Thye King Chan Endowed Professor of Neurosurgery at Stanford University School of Medicine and Vice Chair for Innovation and Technology in the Department of Neurosurgery at Stanford University School of Medicine. Dr. Adler is a pioneer in the field of radiosurgery and the inventor of the CyberKnife Radiosurgical System. He currently focuses on the use of the CyberKnife to help those suffering from refractory major depression and bipolar disorders.

MACARAN BAIRD, MD, MS

Dr. Macaran Baird is head of the University of Minnesota Department of Family Medicine and Community Health, and he chairs the UCare Board of Directors. Dr. Baird’s expertise includes the integration of behavioral medicine into primary care, population-based health, family therapy and chronic illness. He was an integral member of the Robert Woods Johnson Foundation’s Depression in Primary Care Initiative and co-chair of the Institute of Medicine’s Report on Health and Behavior. Dr. Baird and Face It Director Mark Meier frequently lecture together on the management of depression in primary care.

MARK FRYE, MD

Dr. Mark Frye is a psychiatrist and the current chair of the Department of Psychiatry and Psychology at the Mayo Clinic. Dr. Frye’s clinical interests are in bipolar disorder, depression, and alcoholism with a research focus on genomics, brain imaging, and neuroendocrinology of mood disorders and alcoholism. Dr. Frye has published multiple peer-reviewed articles on depression. He has been an integral supporter of Face its community outreach efforts.

IAN H. GOTLIB, PH.D

Dr. Ian H. Gotlib received his Ph.D. in Clinical Psychology from the University of Waterloo in Canada. He is the David Starr Jordan Professor in the Department of Psychology at Stanford University, and Director of the Stanford Mood and Anxiety Disorders Laboratory. Dr. Gotlib is active in clinical research. He examines cognitive, biological, neural, and genetic aspects of the functioning of depressed and anxious children, adolescents, and adults, and of young children at familial risk for depression.

JOHN GREDEN, MD

Dr. John Greden is Executive Director of the University of Michigan Comprehensive Depression Center, the Rachel Upjohn Professor of Psychiatry and Clinical Neurosciences in the Department of Psychiatry, and Research Professor in the Molecular and Behavioral Neuroscience Institute. Dr. Greden is the Founding Chair of the National Network of Depression Centers (NNDC). The NNDC is a network of leading depression centers and academic medical centers that have come together to effect a transformation in the field of mood disorders. They work to make diagnosis affordable, accessible and acceptable.

MADHUKAR TRIVEDI, MD

Dr. Madhukar H. Trivedi, is a professor of psychiatry, the Betty Jo Hay Distinguished Chair in Mental Health, and chief of the division of mood disorders at UT Southwestern. Dr. Trivedi has been a principal investigator in multiple clinical trials funded through NIMH and the Texas Department of Mental Health. Dr. Trivedi is also currently the Co-Director of the Dallas Coordinating Center of the NIMH-funded project called Sequenced Treatment and Alternatives to Relieve Depression (STAR*D). Dr. Trivedi has received numerous awards, including the Gerald L. Klerman award from the National Depressive and Manic-Depressive Association Scientific Advisory Board-NDMDA and the Psychiatric Excellence Award from the Texas Society of Psychiatric Physicians-TSPP.